Lucane Pharma's business model reproduces the successful aspects of others which the management team has first-hand experience.

Lucane Pharma's strategy for growth follows three main pathways: In/out Licensing, Development and Co-development.

Lucane Pharma is actively engaged in the development of 4 products, each of which will offer a significant benefit to patients suffering from very rare disorders who have to take medication every day of their lives to survive or to reduce the pathological complications of their disease.

© Lucane Pharma    |    Legal information ()